Sacituzumab govitecan (solution), CAS 1491917-83-9

Product Description: Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) [published correction appears in Oncotarget. 2020 Mar 10;11(10):942]. Oncotarget. 2015;6(26):22496-22512./[2]Cardillo TM, et al. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug Chem. 2015 May 20;26(5):919-31.

CAS Number: 1491917-83-9

Molecular Weight: N/A

Compound Purity: 96.02

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Antibody-Drug Conjugates (ADCs);TROP2

• Artikelnummer: MEXHY-132254A-50
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-132254A-50
• Green Labware: Nein
• Verpackungseinheit: 50 mg
• Mengeneinheit: STK